{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:39:05Z","timestamp":1792456745261,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08650-9","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:55:11Z","timestamp":1784732111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of the epidermal growth factor receptor (EGFR\/ErbB1) in diabetic retinopathy and its therapeutic implications"],"prefix":"10.1186","volume":"24","author":[{"given":"Marwan","family":"Malluhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Tluli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3177-946X","authenticated-orcid":false,"given":"Saghir","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"8650_CR1","doi-asserted-by":"publisher","unstructured":"Committee ADAPP. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025. Diabetes Care. 2025;48(Supplement_1):48(Supplement_1). https:\/\/doi.org\/10.2337\/dc25-SDIS.","DOI":"10.2337\/dc25-SDIS"},{"issue":"1","key":"8650_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17305\/bb.2025.12222","volume":"26","author":"A Hassanein","year":"2025","unstructured":"Hassanein A, Akhtar S. Recent advances in stem cell-based therapies for type 1 diabetes: a glimpse into the future. Biomol Biomed. 2025;26(1):5\u201323. https:\/\/doi.org\/10.17305\/bb.2025.12222.","journal-title":"Biomol Biomed"},{"key":"8650_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphar.2021.701390","volume":"12","author":"BA Shraim","year":"2021","unstructured":"Shraim BA, Moursi MO, Benter IF, Habib AM, Akhtar S. The role of epidermal growth factor receptor family of receptor tyrosine kinases in mediating diabetes-induced cardiovascular complications. Front Pharmacol. 2021;12:12. https:\/\/doi.org\/10.3389\/fphar.2021.701390.","journal-title":"Front Pharmacol"},{"key":"8650_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fphar.2024.1394997","volume":"15","author":"M Tawengi","year":"2024","unstructured":"Tawengi M, Al-Dali Y, Tawengi A, Benter IF, Akhtar S. Targeting the epidermal growth factor receptor (EGFR\/ErbB) for the potential treatment of renal pathologies. Front Pharmacol. 2024;15:15. https:\/\/doi.org\/10.3389\/fphar.2024.1394997.","journal-title":"Front Pharmacol"},{"issue":"3","key":"8650_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.17305\/bb.2023.10188","volume":"24","author":"S Akhtar","year":"2024","unstructured":"Akhtar S. Diabetes-induced peripheral neuropathy: is prescribing physical exercise the answer? Biomol Biomed. 2024;24(3):436\u201339. https:\/\/doi.org\/10.17305\/bb.2023.10188.","journal-title":"Biomol Biomed"},{"issue":"1","key":"8650_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","volume":"14","author":"M Kropp","year":"2023","unstructured":"Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014risks and mitigation. Epma J. 2023;14(1):21\u201342. https:\/\/doi.org\/10.1007\/s13167-023-00314-8.","journal-title":"Epma J"},{"key":"8650_CR7","doi-asserted-by":"publisher","unstructured":"ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Supplement_1):S252\u201365. https:\/\/doi.org\/10.2337\/dc25-S012.","DOI":"10.2337\/dc25-S012"},{"key":"8650_CR8","doi-asserted-by":"publisher","unstructured":"Wong TY, Cheung CMG, Larsen M, Sharma S, Sim\u00f3 R, et al. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2(1). https:\/\/doi.org\/10.1038\/nrdp.2016.12.","DOI":"10.1038\/nrdp.2016.12"},{"issue":"1","key":"8650_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/dc20-1815","volume":"44","author":"MA Bethel","year":"2021","unstructured":"Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC. HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression. Diabetes Care. 2021;44(1):290\u201396. https:\/\/doi.org\/10.2337\/dc20-1815.","journal-title":"Diabetes Care"},{"issue":"6","key":"8650_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.survophthal.2023.07.002","volume":"68","author":"I Kapoor","year":"2023","unstructured":"Kapoor I, Sarvepalli SM, D\u2019Alessio D, Grewal DS, Hadziahmetovic M. GLP-1 receptor agonists and diabetic retinopathy: a meta-analysis of randomized clinical trials. Surv Ophthalmol. 2023;68(6):1071\u201383. https:\/\/doi.org\/10.1016\/j.survophthal.2023.07.002.","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"8650_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00125-024-06132-5","volume":"67","author":"A Eleftheriadou","year":"2024","unstructured":"Eleftheriadou A, Riley D, Zhao SS, Austin P, Hern\u00e1ndez G, Lip GYH, et al. Risk of diabetic retinopathy and diabetic macular oedema with sodium\u2013glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia. 2024;67(7):1271\u201382. https:\/\/doi.org\/10.1007\/s00125-024-06132-5.","journal-title":"Diabetologia"},{"issue":"6","key":"8650_CR12","doi-asserted-by":"publisher","first-page":"101696","DOI":"10.1016\/j.diabet.2025.101696","volume":"51","author":"K Liu","year":"2025","unstructured":"Liu K, Liu S, Wang D, Qiao H. Are GLP-1 receptor agonists and diabetic retinopathy foes or friends? Diabetes Metab. 2025;51(6):101696. https:\/\/doi.org\/10.1016\/j.diabet.2025.101696.","journal-title":"Diabetes Metab"},{"issue":"7","key":"8650_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaophthalmol.2025.1455","volume":"143","author":"R Shor","year":"2025","unstructured":"Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, et al. Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration. JAMA Ophthalmol. 2025;143(7):587. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.1455.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"8650_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/pharmaceutics17010099","volume":"17","author":"Q Wen","year":"2025","unstructured":"Wen Q, Karcher H, Wright DM, Sinha SB, Chakravarthy U, Santos C, et al. Visual acuity outcomes and influencing factors in a cohort of UK real-world diabetic macular oedema patients during the first two years of anti-VEGF treatment. Pharmaceutics. 2025;17(1):99. https:\/\/doi.org\/10.3390\/pharmaceutics17010099.","journal-title":"Pharmaceutics"},{"key":"8650_CR15","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.preteyeres.2020.100903","volume":"82","author":"S Roy","year":"2021","unstructured":"Roy S, Kim D. Retinal capillary basement membrane thickening: role in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2021;82:100903. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100903.","journal-title":"Prog Retin Eye Res"},{"key":"8650_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.exer.2025.110243","volume":"251","author":"K Otsuka","year":"2025","unstructured":"Otsuka K, Morita A, Kashihara T, Nakahara T. Pharmacological depletion of pericytes induces diabetic retinopathy-like abnormal blood vessels in neonatal rat retina. Exp Eye Res. 2025;251:251. https:\/\/doi.org\/10.1016\/j.exer.2025.110243.","journal-title":"Exp Eye Res"},{"issue":"1","key":"8650_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40942-023-00521-5","volume":"10","author":"S Ari Widjaja","year":"2024","unstructured":"Ari Widjaja S, Mieler WF, Sasono W, Soelistijo SA, Kartasasmita AS, Murakami A, et al. Retinal neurovascular alteration in type 2 diabetes with renal impairment in association with systemic arterial stiffness. Int J Retin Vitr. 2024;10(1):2. https:\/\/doi.org\/10.1186\/s40942-023-00521-5.","journal-title":"Int J Retin Vitr"},{"issue":"5","key":"8650_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells14050376","volume":"14","author":"H Seo","year":"2025","unstructured":"Seo H, Park S-J, Song M. Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies. Cells. 2025;14(5):376. https:\/\/doi.org\/10.3390\/cells14050376.","journal-title":"Cells"},{"issue":"9","key":"8650_CR19","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.3390\/ijms26093961","volume":"26","author":"A Malepati","year":"2025","unstructured":"Malepati A, Grant MB. The role and diagnostic potential of insulin-like growth factor 1 in diabetic retinopathy and diabetic macular edema. IJMS. 2025;26(9):3961. https:\/\/doi.org\/10.3390\/ijms26093961.","journal-title":"IJMS"},{"issue":"11","key":"8650_CR20","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.3390\/ijms26114992","volume":"26","author":"A Callan","year":"2025","unstructured":"Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin A. VEGF in diabetic retinopathy and age-related macular degeneration. IJMS. 2025;26(11):4992. https:\/\/doi.org\/10.3390\/ijms26114992.","journal-title":"IJMS"},{"issue":"10","key":"8650_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","volume":"22","author":"G Uludag","year":"2022","unstructured":"Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Than NTT, et al. Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? Expert Opin Biol Ther. 2022;22(10):1275\u201391. https:\/\/doi.org\/10.1080\/14712598.2022.2100694.","journal-title":"Expert Opin Biol Ther"},{"key":"8650_CR22","doi-asserted-by":"publisher","unstructured":"Li J, Chen K, Li X, Zhang X, Zhang L, Yang Q, et al. Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. Cell Death Discov. 2023;9(1). https:\/\/doi.org\/10.1038\/s41420-023-01717-2.","DOI":"10.1038\/s41420-023-01717-2"},{"issue":"12","key":"8650_CR23","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1007\/s00417-024-06558-y","volume":"262","author":"S Nakao","year":"2024","unstructured":"Nakao S, Kusuhara S, Murakami T. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology. Graefes Arch Clin Exp Ophthalmol. 2024;262(12):3749\u201359. https:\/\/doi.org\/10.1007\/s00417-024-06558-y.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"8650_CR24","doi-asserted-by":"publisher","unstructured":"Hodgson R, Walton M, Fulbright H, Bojke L, Walker R, Llewellyn A, et al. A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy. Health Technol Assess. 2025;1\u201319. https:\/\/doi.org\/10.3310\/NHYK3694.","DOI":"10.3310\/NHYK3694"},{"issue":"4","key":"8650_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2337\/dc13-1990","volume":"37","author":"N Cheung","year":"2014","unstructured":"Cheung N, Wong IY, Wong TY. Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications. Diabetes Care. 2014;37(4):900\u201305. https:\/\/doi.org\/10.2337\/dc13-1990.","journal-title":"Diabetes Care"},{"key":"8650_CR26","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2147\/OPTH.S399981","volume":"Volume 17","author":"S Somani","year":"2023","unstructured":"Somani S, Koushan K, Shah-Manek B, Mercer D, Kanagenthiran T, Zhao C, et al. Characteristics and treatment patterns of patients with diabetic macular edema non-responsive to anti-vascular endothelial growth factor treatment in Ontario, Canada. OPTH. 2023;Volume 17:2013\u201325. https:\/\/doi.org\/10.2147\/OPTH.S399981.","journal-title":"OPTH"},{"issue":"2","key":"8650_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.oret.2024.08.004","volume":"9","author":"M-M Macaron","year":"2025","unstructured":"Macaron M-M, Sabbakh NA, Shami MZ, Akrobetu D, Bourdakos NE, Abdulsalam FAM, et al. Anti-VEGF injections vs. Panretinal photocoagulation laser therapy for proliferative diabetic retinopathy: a systematic review and meta-analysis. Ophthalmol Retina. 2025;9(2):105\u201321. https:\/\/doi.org\/10.1016\/j.oret.2024.08.004.","journal-title":"Ophthalmol Retina"},{"key":"8650_CR28","doi-asserted-by":"publisher","unstructured":"Lim JW, Lee SJ, Sung JY, Kim J-S, Nam KY, et al. Effect of prophylactic anti-VEGF injections on the prevention of recurrent vitreous hemorrhage in PDR patients after PRP. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-17214-y.","DOI":"10.1038\/s41598-022-17214-y"},{"issue":"9","key":"8650_CR29","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.medj.2025.100747","volume":"6","author":"F Pereira","year":"2025","unstructured":"Pereira F, Magagnoli J, Ambati M, Fernandes de Oliveira T, Estev\u00e3o de Oliveira JA, Pesquero VO, et al. Oral lamivudine in diabetic macular edema: a randomized, double-blind, placebo-controlled clinical trial. Med. 2025;6(9):100747. https:\/\/doi.org\/10.1016\/j.medj.2025.100747.","journal-title":"Med"},{"issue":"1","key":"8650_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells13010047","volume":"13","author":"N Shaban","year":"2023","unstructured":"Shaban N, Kamashev D, Emelianova A, Buzdin A, et al. Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications. Cells. 2023;13(1):47. https:\/\/doi.org\/10.3390\/cells13010047.","journal-title":"Cells"},{"issue":"5","key":"8650_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 2017;9(5):52. https:\/\/doi.org\/10.3390\/cancers9050052.","journal-title":"Cancers"},{"issue":"1","key":"8650_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-023-00523-5","volume":"9","author":"X Bai","year":"2023","unstructured":"Bai X, Sun P, Wang X, Long C, Liao S, Dang S, et al. Structure and dynamics of the EGFR\/HER2 heterodimer. Cell Discov. 2023;9(1):18. https:\/\/doi.org\/10.1038\/s41421-023-00523-5.","journal-title":"Cell Discov"},{"issue":"1","key":"8650_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-025-01119-9","volume":"32","author":"C Tito","year":"2025","unstructured":"Tito C, Masciarelli S, Colotti G, Fazi F. EGF receptor in organ development, tissue homeostasis and regeneration. J Biomed Sci. 2025;32(1):24. https:\/\/doi.org\/10.1186\/s12929-025-01119-9.","journal-title":"J Biomed Sci"},{"issue":"6","key":"8650_CR34","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/pro.3871","volume":"29","author":"KM Ferguson","year":"2020","unstructured":"Ferguson KM, Hu C, Lemmon MA. Insulin and epidermal growth factor receptor family members share parallel activation mechanisms. Protein Sci. 2020;29(6):1331\u201344. https:\/\/doi.org\/10.1002\/pro.3871.","journal-title":"Protein Sci"},{"key":"8650_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","volume":"85","author":"E Levantini","year":"2022","unstructured":"Levantini E, Maroni G, Del Re M, Tenen DG. EGFR signaling pathway as therapeutic target in human cancers. Semin Cancer Biol. 2022;85:253\u201375. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.002.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8650_CR36","doi-asserted-by":"publisher","first-page":"11414","DOI":"10.1038\/s41598-021-90716-3","volume":"11","author":"O Zbodakova","year":"2021","unstructured":"Zbodakova O, Chalupsky K, Sarnova L, Kasparek P, Jirouskova M, Gregor M, et al. ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis. Sci Rep. 2021;11(1):11414. https:\/\/doi.org\/10.1038\/s41598-021-90716-3.","journal-title":"Sci Rep"},{"key":"8650_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2016.00088","volume":"4","author":"SP Kennedy","year":"2016","unstructured":"Kennedy SP, Hastings JF, Han JZR, Croucher DR. The under-appreciated promiscuity of the epidermal growth factor receptor family. Front Cell Dev Biol. 2016;4:4. https:\/\/doi.org\/10.3389\/fcell.2016.00088.","journal-title":"Front Cell Dev Biol"},{"issue":"7261","key":"8650_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature08297","volume":"461","author":"D Alvarado","year":"2009","unstructured":"Alvarado D, Klein DE, Lemmon MA. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature. 2009;461(7261):287\u201391. https:\/\/doi.org\/10.1038\/nature08297.","journal-title":"Nature"},{"issue":"1","key":"8650_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exer.2004.02.017","volume":"79","author":"DM Defoe","year":"2004","unstructured":"Defoe DM, Grindstaff RD. Epidermal growth factor stimulation of RPE cell survival: contribution of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Exp Eye Res. 2004;79(1):51\u201359. https:\/\/doi.org\/10.1016\/j.exer.2004.02.017.","journal-title":"Exp Eye Res"},{"issue":"2","key":"8650_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.devcel.2011.11.020","volume":"22","author":"J Wan","year":"2012","unstructured":"Wan J, Ramachandran R, Goldman D. HB-EGF is necessary and sufficient for m\u00fcller glia dedifferentiation and retina regeneration. Dev Cell. 2012;22(2):334\u201347. https:\/\/doi.org\/10.1016\/j.devcel.2011.11.020.","journal-title":"Dev Cell"},{"key":"8650_CR41","doi-asserted-by":"publisher","unstructured":"Dong L, Shi XH, Kang YK, Wei WB, Wang YX, Xu XL, et al. Amphiregulin and ocular axial length. Acta Ophthalmologica. 2019;97(3). https:\/\/doi.org\/10.1111\/aos.14080.","DOI":"10.1111\/aos.14080"},{"issue":"1","key":"8650_CR42","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/jcmm.13321","volume":"22","author":"D Zhang","year":"2018","unstructured":"Zhang D, Shen B, Zhang Y, Ni N, Wang Y, Fan X, et al. Betacellulin regulates the proliferation and differentiation of retinal progenitor cells in vitro. J Cellular Mol Medi. 2018;22(1):330\u201345. https:\/\/doi.org\/10.1111\/jcmm.13321.","journal-title":"J Cellular Mol Medi"},{"issue":"4","key":"8650_CR43","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1167\/iovs.11-8869","volume":"53","author":"Y Z","year":"2012","unstructured":"Z Y, K T, H Y, Y R, S A, S S, et al. Important role of epiregulin in inflammatory responses during corneal epithelial wound healing. Invest. Ophthalmol Vis Sci. 2012;53(4):2414. https:\/\/doi.org\/10.1167\/iovs.11-8869.","journal-title":"Invest. Ophthalmol Vis Sci"},{"issue":"21","key":"8650_CR44","doi-asserted-by":"publisher","first-page":"18265","DOI":"10.1074\/jbc.M006935200","volume":"276","author":"L Strachan","year":"2001","unstructured":"Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem. 2001;276(21):18265\u201371. https:\/\/doi.org\/10.1074\/jbc.M006935200.","journal-title":"J Biol Chem"},{"key":"8650_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.theriogenology.2024.01.020","volume":"218","author":"D Biswas","year":"2024","unstructured":"Biswas D, Yoon JD, Mishra B, Hyun SH. Epigen enhances the developmental potential of in vitro fertilized embryos by improving cytoplasmic maturation. Theriogenology. 2024;218:16\u201325. https:\/\/doi.org\/10.1016\/j.theriogenology.2024.01.020.","journal-title":"Theriogenology"},{"issue":"5","key":"8650_CR46","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.pharmr.2025.100076","volume":"77","author":"Y Du","year":"2025","unstructured":"Du Y, Karatekin F, Wang WK, Hong W, Boopathy GTK. Cracking the EGFR code: cancer biology, resistance mechanisms, and future therapeutic frontiers. Pharmacol Rev. 2025;77(5):100076. https:\/\/doi.org\/10.1016\/j.pharmr.2025.100076.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"8650_CR47","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1755-3768.2008.01434.x","volume":"87","author":"S Akhtar","year":"2009","unstructured":"Akhtar S, Almubrad T, Bron AJ, Yousif MHM, Benter IF, Akhtar S. Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmologica. 2009;87(8):881\u201389. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01434.x.","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"8650_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/1440-1681.13029","volume":"46","author":"X Ju","year":"2019","unstructured":"Ju X, Yang X, Yan T, Chen H, Song Z, Zhang Z, et al. EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy. Clin Exp Pharma Physio. 2019;46(1):75\u201385. https:\/\/doi.org\/10.1111\/1440-1681.13029.","journal-title":"Clin Exp Pharma Physio"},{"key":"8650_CR49","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhang X, Chen K, Wang Y. The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1. J Transl Med. 2025;23(1). https:\/\/doi.org\/10.1186\/s12967-025-07357-7.","DOI":"10.1186\/s12967-025-07357-7"},{"issue":"5","key":"8650_CR50","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1167\/iovs.06-0560","volume":"48","author":"KP Xu","year":"2007","unstructured":"Xu KP, Yu F-SX. Cross talk between c-met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Invest. Ophthalmol Vis Sci. 2007;48(5):2242\u201348. https:\/\/doi.org\/10.1167\/iovs.06-0560.","journal-title":"Invest. Ophthalmol Vis Sci"},{"key":"8650_CR51","doi-asserted-by":"publisher","unstructured":"Lee YM, Sun YH. Maintenance of glia in the optic lamina is mediated by EGFR signaling by photoreceptors in adult Drosophila. PLoS Genet. 2015;11(4):e1005187. https:\/\/doi.org\/10.1371\/journal.pgen.1005187.","DOI":"10.1371\/journal.pgen.1005187"},{"key":"8650_CR52","doi-asserted-by":"publisher","unstructured":"Yogev S, Schejter ED, Shilo BZ. Polarized secretion of drosophila EGFR ligand from photoreceptor neurons is controlled by ER localization of the ligand-processing machinery. PLoS Biol. 2010;8(10):e1000505. https:\/\/doi.org\/10.1371\/journal.pbio.1000505.","DOI":"10.1371\/journal.pbio.1000505"},{"key":"8650_CR53","doi-asserted-by":"publisher","unstructured":"Pasnuri N, Jaiswal M, Ray K, Mazumder A. Buffered EGFR signaling regulated by spitz-to-argos expression ratio is a critical factor for patterning the drosophila eye. PLoS Genet. 2023;19(2):e1010622. https:\/\/doi.org\/10.1371\/journal.pgen.1010622.","DOI":"10.1371\/journal.pgen.1010622"},{"key":"8650_CR54","doi-asserted-by":"publisher","unstructured":"Harun-Or-Rashid M, Konjusha D, Galindo-Romero C, Hallb\u00f6\u00f6k F. Endothelin B receptors on primary chicken M\u00fcller cells and the human MIO-M1 M\u00fcller cell line activate ERK signaling via Transactivation of epidermal growth Factor receptors. PLoS One. 2016;11(12):e0167778. https:\/\/doi.org\/10.1371\/journal.pone.0167778.","DOI":"10.1371\/journal.pone.0167778"},{"issue":"11","key":"8650_CR55","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3760\/cma.j.cn112142-20230210-00053","volume":"59","author":"M Zhu","year":"2023","unstructured":"Zhu M, Zhao Q, Sun Y, Song E. [Experimental study on the therapeutic effect and mechanism of erlotinib on non-proliferative diabetic retinopathy]. Zhonghua Yan Ke Za Zhi. 2023;59(11):906\u201318. https:\/\/doi.org\/10.3760\/cma.j.cn112142-20230210-00053.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"4","key":"8650_CR56","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1158\/0008-5472.CAN-05-3387","volume":"66","author":"DN Amin","year":"2006","unstructured":"Amin DN, Hida K, Bielenberg DR, Klagsbrun M. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res. 2006;66(4):2173\u201380. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3387.","journal-title":"Cancer Res"},{"key":"8650_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.exer.2025.110750","volume":"262","author":"W Zhang","year":"2026","unstructured":"Zhang W, Zhang X, Chen K. Epidermal growth factor receptor promotes diabetic retinal fibrogenesis via YAP-CCN2-dependent manner. Exp Eye Res. 2026;262:262. https:\/\/doi.org\/10.1016\/j.exer.2025.110750.","journal-title":"Exp Eye Res"},{"issue":"22","key":"8650_CR58","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1182\/blood-2010-05-286872","volume":"116","author":"AN Stratman","year":"2010","unstructured":"Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood. 2010;116(22):4720\u201330. https:\/\/doi.org\/10.1182\/blood-2010-05-286872.","journal-title":"Blood"},{"issue":"15","key":"8650_CR59","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1523\/JNEUROSCI.5169-09.2010","volume":"30","author":"M Calvo","year":"2010","unstructured":"Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, et al. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to Microgliosis and pain after peripheral nerve injury. J Neurosci. 2010;30(15):5437\u201350. https:\/\/doi.org\/10.1523\/JNEUROSCI.5169-09.2010.","journal-title":"J Neurosci"},{"key":"8650_CR60","doi-asserted-by":"publisher","unstructured":"Guo C, Sodhi A. Molecular stress and neurovascular injury in the diabetic retina. J Clin Investigation. 2026;136(5). https:\/\/doi.org\/10.1172\/JCI200945.","DOI":"10.1172\/JCI200945"},{"key":"8650_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcell.2022.1047487","volume":"10","author":"S Yang","year":"2022","unstructured":"Yang S, Qi S, Wang C. The role of retinal m\u00fcller cells in diabetic retinopathy and related therapeutic advances. Front Cell Dev Biol. 2022;10:10. https:\/\/doi.org\/10.3389\/fcell.2022.1047487.","journal-title":"Front Cell Dev Biol"},{"key":"8650_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00843","volume":"10","author":"SH Sinclair","year":"2019","unstructured":"Sinclair SH, Schwartz SS. Diabetic retinopathy\u2013an underdiagnosed and undertreated inflammatory, neuro-vascular complication of diabetes. Front Endocrinol. 2019;10:10. https:\/\/doi.org\/10.3389\/fendo.2019.00843.","journal-title":"Front Endocrinol"},{"issue":"11","key":"8650_CR63","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","volume":"24","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. IJMS. 2023;24(11):9352. https:\/\/doi.org\/10.3390\/ijms24119352.","journal-title":"IJMS"},{"issue":"26","key":"8650_CR64","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.2174\/09298673113209990025","volume":"20","author":"M Chen","year":"2013","unstructured":"Chen M, Curtis TM, Stitt AW. Advanced glycation end products and diabetic retinopathy. CMC. 2013;20(26):3234\u201340. https:\/\/doi.org\/10.2174\/09298673113209990025.","journal-title":"CMC"},{"key":"8650_CR65","doi-asserted-by":"publisher","unstructured":"Zhou L, Mo Y, Zhang H, Zhang M, Xu J, Liang S. Role of AMPK-regulated autophagy in retinal pigment epithelial cell homeostasis: a review. Med (Baltim). 2024;103(28):e38908. https:\/\/doi.org\/10.1097\/MD.0000000000038908.","DOI":"10.1097\/MD.0000000000038908"},{"issue":"4","key":"8650_CR66","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Aspects Med. 2012;33(4):295\u2013317. https:\/\/doi.org\/10.1016\/j.mam.2012.04.005.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"8650_CR67","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195\u2013206. https:\/\/doi.org\/10.1038\/s41574-020-00451-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"8650_CR68","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/ejn.13965","volume":"47","author":"PV Subirada","year":"2018","unstructured":"Subirada PV, Paz MC, Ridano ME, Lorenc VE, Vaglienti MV, Barcelona PF, et al. A journey into the retina: m\u00fcller glia commanding survival and death. Eur J Neurosci. 2018;47(12):1429\u201343. https:\/\/doi.org\/10.1111\/ejn.13965.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"8650_CR69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2337\/db23-0368","volume":"73","author":"X Yao","year":"2024","unstructured":"Yao X, Zhao Z, Zhang W, Liu R, Ni T, Cui B, et al. Specialized retinal endothelial cells modulate blood-retina barrier in diabetic retinopathy. Diabetes. 2024;73(2):225\u201336. https:\/\/doi.org\/10.2337\/db23-0368.","journal-title":"Diabetes"},{"key":"8650_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia UM, Wolf A, Langmann T. Frontiers | microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020;11:11. https:\/\/doi.org\/10.3389\/fimmu.2020.564077.","journal-title":"Front. Immunol"},{"issue":"7","key":"8650_CR71","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4239\/wjd.v14.i7.1013","volume":"14","author":"ML Robles-Osorio","year":"2023","unstructured":"Robles-Osorio ML, Sabath E. Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: a narrative review. World J Diabetes. 2023;14(7):1013\u201326. https:\/\/doi.org\/10.4239\/wjd.v14.i7.1013.","journal-title":"World J Diabetes"},{"issue":"4","key":"8650_CR72","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jdi.70000","volume":"16","author":"H Yamaguchi","year":"2025","unstructured":"Yamaguchi H, Nagai R. Insights from the fructose-derived product glucoselysine: revisiting the polyol pathway in diabetic complications. J Diabetes Invest. 2025;16(4):569\u201377. https:\/\/doi.org\/10.1111\/jdi.70000.","journal-title":"J Diabetes Invest"},{"key":"8650_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fendo.2026.1771836","volume":"17","author":"C Carrillo","year":"2026","unstructured":"Carrillo C, Belecky-Adams TL, Sheibani N. Diabetes associated pericyte metabolic signatures and pathogenesis of diabetic retinopathy. Front Endocrinol. 2026;17:17. https:\/\/doi.org\/10.3389\/fendo.2026.1771836.","journal-title":"Front Endocrinol"},{"key":"8650_CR74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/DMSO.S106087","volume":"9","author":"J Yan","year":"2016","unstructured":"Yan J, Wu J, Jin Z, Zheng H. Sources and implications of NADH\/NAD+ redox imbalance in diabetes and its complications. DMSO. 2016;9:145\u201353. https:\/\/doi.org\/10.2147\/DMSO.S106087.","journal-title":"DMSO"},{"key":"8650_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/801269","volume":"2014","author":"SZ Safi","year":"2014","unstructured":"Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail ISB. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 2014;2014:1\u201318. https:\/\/doi.org\/10.1155\/2014\/801269.","journal-title":"Biomed Res Int"},{"key":"8650_CR76","doi-asserted-by":"publisher","first-page":"973058","DOI":"10.3389\/fendo.2022.973058","volume":"13","author":"D Pan","year":"2022","unstructured":"Pan D, Xu L, Guo M. The role of protein kinase C in diabetic microvascular complications. Front Endocrinol. 2022;13:973058. https:\/\/doi.org\/10.3389\/fendo.2022.973058.","journal-title":"Front Endocrinol"},{"key":"8650_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester JV, Kuffova L, Delibegovic M. The role of inflammation in diabetic retinopathy. Front. Immunol. 2020;11:11. https:\/\/doi.org\/10.3389\/fimmu.2020.583687.","journal-title":"Front. Immunol"},{"key":"8650_CR78","doi-asserted-by":"publisher","unstructured":"Giblin MJ, Ontko CD, Penn JS. Effect of cytokine-induced alterations in extracellular matrix composition on diabetic retinopathy-relevant endothelial cell behaviors. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-12683-7.","DOI":"10.1038\/s41598-022-12683-7"},{"issue":"1","key":"8650_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.yexcr.2014.08.040","volume":"331","author":"X Liu","year":"2015","unstructured":"Liu X, Ye F, Xiong H, Hu D-N, Limb GA, Xie T, et al. IL-1\u03b2 induces IL-6 production in retinal m\u00fcller cells predominantly through the activation of P38 MAPK\/NF-\u03baB signaling pathway. Exp Cell Res. 2015;331(1):223\u201331. https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.040.","journal-title":"Exp Cell Res"},{"issue":"2","key":"8650_CR80","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/glia.20361","volume":"54","author":"JL Close","year":"2006","unstructured":"Close JL, Liu J, Gumuscu B, Reh TA. Epidermal growth factor receptor expression regulates proliferation in the postnatal rat retina. Glia. 2006;54(2):94\u2013104. https:\/\/doi.org\/10.1002\/glia.20361.","journal-title":"Glia"},{"issue":"2","key":"8650_CR81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cne.21161","volume":"500","author":"H Chen","year":"2007","unstructured":"Chen H, Liu B, Neufeld AH. Epidermal growth factor receptor in adult retinal neurons of rat, mouse, and human. J Comp Neurol. 2007;500(2):299\u2013310. https:\/\/doi.org\/10.1002\/cne.21161.","journal-title":"J Comp Neurol"},{"issue":"6","key":"8650_CR82","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0706238","volume":"145","author":"IF Benter","year":"2005","unstructured":"Benter IF, Yousif MHM, Griffiths SM, Benboubetra M, Akhtar S. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed. Br J Pharmacol. 2005;145(6):829\u201336. https:\/\/doi.org\/10.1038\/sj.bjp.0706238.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"8650_CR83","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000085904","volume":"42","author":"IF Benter","year":"2005","unstructured":"Benter IF, Yousif MHM, Hollins AJ, Griffiths SM, Akhtar S. Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase. J Vasc Res. 2005;42(4):284\u201391. https:\/\/doi.org\/10.1159\/000085904.","journal-title":"J Vasc Res"},{"issue":"1","key":"8650_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/dmrr.1050","volume":"26","author":"K Matrougui","year":"2010","unstructured":"Matrougui K. Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase. Diabetes Metab Res. 2010;26(1):13\u201316. https:\/\/doi.org\/10.1002\/dmrr.1050.","journal-title":"Diabetes Metab Res"},{"issue":"2","key":"8650_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1474-8673.2004.00333.x","volume":"25","author":"MHM Yousif","year":"2005","unstructured":"Yousif MHM, Benter IF, Akhtar S. The role of tyrosine kinase-mediated pathways in diabetes-induced alterations in responsiveness of rat carotid artery. Auton Autocoid Pharmacol. 2005;25(2):69\u201378. https:\/\/doi.org\/10.1111\/j.1474-8673.2004.00333.x.","journal-title":"Auton Autocoid Pharmacol"},{"issue":"4","key":"8650_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.vph.2009.06.008","volume":"51","author":"IF Benter","year":"2009","unstructured":"Benter IF, Benboubetra M, Hollins AJ, Yousif MHM, Canatan H, Akhtar S. Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature. Vascul Pharmacol. 2009;51(4):236\u201345. https:\/\/doi.org\/10.1016\/j.vph.2009.06.008.","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"8650_CR87","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/1061186X.2015.1057150","volume":"23","author":"IF Ibrahim F Benter","year":"2015","unstructured":"Ibrahim F Benter IF, Sarkhou F, Al-Khaldi AT, Chandrasekhar B, Attur GS, Dhaunsi GS, et al. The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes. J Drug Targeting. 2015;23(6):506\u201318. https:\/\/doi.org\/10.3109\/1061186X.2015.1057150.","journal-title":"J Drug Targeting"},{"key":"8650_CR88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nano.2019.02.012","volume":"18","author":"S Akhtar","year":"2019","unstructured":"Akhtar S, Chandrasekhar B, Yousif MH, Renno W, Benter IF, El-Hashim AZ. Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1\/2-ROCK signaling pathway and attenuates diabetes-induced vascular remodeling and dysfunction. Nanomed: Nanotechnol, Biol Med. 2019;18:78\u201389. https:\/\/doi.org\/10.1016\/j.nano.2019.02.012.","journal-title":"Nanomed: Nanotechnol, Biol Med"},{"key":"8650_CR89","doi-asserted-by":"publisher","unstructured":"Akhtar S, Chandrasekhar B, Attur S, Dhaunsi GS, Yousif MHM, Benter IF. Transactivation of ErbB family of receptor tyrosine kinases is inhibited by angiotensin-(1-7) via its mas receptor. PLoS One. 2015;10(11):e0141657. https:\/\/doi.org\/10.1371\/journal.pone.0141657.","DOI":"10.1371\/journal.pone.0141657"},{"issue":"Supplement_1","key":"8650_CR90","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2337\/db20-455-P","volume":"69","author":"S Akhtar","year":"2020","unstructured":"Akhtar S, Chandrasekhar B, Benter I. 455-P: pan-ErbB inhibition attenuates diabetes-induced vascular dysfunction in an experimental Model of diabetes. Diabetes. 2020;69(Supplement_1):69. https:\/\/doi.org\/10.2337\/db20-455-P.","journal-title":"Diabetes"},{"issue":"3","key":"8650_CR91","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ajpath.2013.05.017","volume":"183","author":"M Sugimoto","year":"2013","unstructured":"Sugimoto M, Cutler A, Shen B, Moss SE, Iyengar SK, Klein R, et al. Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage. Am J Pathol. 2013;183(3):987\u201395. https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.017.","journal-title":"Am J Pathol"},{"issue":"1","key":"8650_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/10799893.2020.1783556","volume":"41","author":"L Zhou","year":"2021","unstructured":"Zhou L, Zhang S, Zhang L, Li F, Sun H, Feng J. MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR\/PI3K\/AKT pathway. J Recept Signal Transduct Res. 2021;41(1):19\u201331. https:\/\/doi.org\/10.1080\/10799893.2020.1783556.","journal-title":"J Recept Signal Transduct Res"},{"key":"8650_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbrc.2021.05.027","volume":"561","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li L, Pan N, Gu J, Qiu Z, Cao G, et al. TNF-\u03b1 released from retinal m\u00fcller cells aggravates retinal pigment epithelium cell apoptosis by upregulating mitophagy during diabetic retinopathy. Biochem Bioph Res Co. 2021;561:143\u201350. https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.027.","journal-title":"Biochem Bioph Res Co"},{"key":"8650_CR94","doi-asserted-by":"publisher","unstructured":"Anand-Apte B, Ebrahem Q, Cutler A, Farage E, Sugimoto M, Hollyfield J, et al. Betacellulin induces increased retinal vascular permeability in mice. PLoS One. 2010;5(10):e13444. https:\/\/doi.org\/10.1371\/journal.pone.0013444.","DOI":"10.1371\/journal.pone.0013444"},{"issue":"9","key":"8650_CR95","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/bjo.78.9.714","volume":"78","author":"B Patel","year":"1994","unstructured":"Patel B, Hiscott P, Charteris D, Mather J, McLeod D, Boulton M. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol. 1994;78(9):714\u201318. https:\/\/doi.org\/10.1136\/bjo.78.9.714.","journal-title":"Br J Ophthalmol"},{"key":"8650_CR96","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.lfs.2024.122483","volume":"340","author":"Y Xian","year":"2024","unstructured":"Xian Y, Wang X, Yu Y, Chen X. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K\/AKT\/VEGFA pathway. Life Sci. 2024;340:340. https:\/\/doi.org\/10.1016\/j.lfs.2024.122483.","journal-title":"Life Sci"},{"issue":"8","key":"8650_CR97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.63.8.24","volume":"63","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li J. EGF receptor signaling modulates YAP activation and promotes experimental proliferative vitreoretinopathy. Invest. Ophthalmol Vis Sci. 2022;63(8):24. https:\/\/doi.org\/10.1167\/iovs.63.8.24.","journal-title":"Invest. Ophthalmol Vis Sci"},{"issue":"1","key":"8650_CR98","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/ATVBAHA.117.310337","volume":"38","author":"Y Inoue","year":"2018","unstructured":"Inoue Y, Shimazawa M, Nakamura S, Takata S, Hashimoto Y, Izawa H, et al. Both autocrine signaling and paracrine signaling of HB-EGF enhance ocular neovascularization. ATVB. 2018;38(1):174\u201385. https:\/\/doi.org\/10.1161\/ATVBAHA.117.310337.","journal-title":"ATVB"},{"issue":"10","key":"8650_CR99","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/02713680600888807","volume":"31","author":"M Hollborn","year":"2006","unstructured":"Hollborn M, Iandiev I, Seifert M, Schnurrbusch UEK, Wolf S, Wiedemann P, et al. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res. 2006;31(10):863\u201374. https:\/\/doi.org\/10.1080\/02713680600888807.","journal-title":"Curr Eye Res"},{"issue":"12","key":"8650_CR100","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1210\/en.2005-0418","volume":"146","author":"MR Schneider","year":"2005","unstructured":"Schneider MR, Dahlhoff M, Herbach N, Renner-Mueller I, Dalke C, Puk O, et al. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. Endocrinology. 2005;146(12):5237\u201346. https:\/\/doi.org\/10.1210\/en.2005-0418.","journal-title":"Endocrinology"},{"issue":"10","key":"8650_CR101","doi-asserted-by":"publisher","first-page":"17269","DOI":"10.1002\/jcp.28344","volume":"234","author":"J Shao","year":"2019","unstructured":"Shao J, Pan X, Yin X, Fan G, Tan C, Yao Y, et al. KCNQ1OT1 affects the progression of diabetic retinopathy by regulating miR-1470 and epidermal growth factor receptor. J Cellular Physiol. 2019;234(10):17269\u201379. https:\/\/doi.org\/10.1002\/jcp.28344.","journal-title":"J Cellular Physiol"},{"issue":"6","key":"8650_CR102","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/brainsci10060330","volume":"10","author":"JS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a JS, Vazquez M. VEGF Upregulates EGFR expression to stimulate chemotactic behaviors in the rMC-1 Model of M\u00fcller glia. Brain Sci. 2020;10(6):330. https:\/\/doi.org\/10.3390\/brainsci10060330.","journal-title":"Brain Sci"},{"key":"8650_CR103","unstructured":"S-Rz Y-SZ, Zhang H-H, Wang T, Chen X-D. Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell via EGFR\/AKT signaling pathway. Int J Ophthalmol. 2024;17(6)."},{"key":"8650_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fendo.2025.1664604","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Zhang J, Li C, Wang L, Tao L, Xue S, et al. Targeting microRNAs in diabetic retinopathy: from pathogenic mechanisms to therapeutic potentials. Front Endocrinol. 2025;16:16. https:\/\/doi.org\/10.3389\/fendo.2025.1664604.","journal-title":"Front Endocrinol"},{"key":"8650_CR105","doi-asserted-by":"publisher","unstructured":"Luo Y, Li C. Advances in research related to MicroRNA for diabetic retinopathy. J Diabetes Res. 2024;2024(1). https:\/\/doi.org\/10.1155\/2024\/8520489.","DOI":"10.1155\/2024\/8520489"},{"key":"8650_CR106","doi-asserted-by":"publisher","unstructured":"Xia &, Yang &, Zheng &, Yi &, Wu &. Plasma levels and diagnostic significance of miR-335-3p and EGFR in diabetic retinopathy. Clin Lab. 2022;68(04\/2022). https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210447.","DOI":"10.7754\/Clin.Lab.2021.210447"},{"key":"8650_CR107","doi-asserted-by":"publisher","unstructured":"Bohler F, Bohler L, Taranikanti V. Targeting pericyte retention in diabetic retinopathy: a review. Ann Med. 2024;56(1). https:\/\/doi.org\/10.1080\/07853890.2024.2398200.","DOI":"10.1080\/07853890.2024.2398200"},{"key":"8650_CR108","doi-asserted-by":"publisher","unstructured":"Park DY, Lee J, Kim J, Kim K, Hong S, Han S, et al. Plastic roles of pericytes in the blood\u2013retinal barrier. Nat Commun. 2017;8, 8(1):1. https:\/\/doi.org\/10.1038\/ncomms15296.","DOI":"10.1038\/ncomms15296"},{"issue":"3","key":"8650_CR109","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archopht.1968.00980050334007","volume":"80","author":"P Speiser","year":"1968","unstructured":"Speiser P. Studies on diabetic retinopathy. Arch Ophthalmol. 1968;80(3):332. https:\/\/doi.org\/10.1001\/archopht.1968.00980050334007.","journal-title":"Arch Ophthalmol"},{"key":"8650_CR110","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.preteyeres.2025.101349","volume":"106","author":"AI Jobling","year":"2025","unstructured":"Jobling AI, Greferath U, Dixon MA, Quiriconi P, Eyar B, van Koeverden K, et al. Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes. Prog Retin Eye Res. 2025;106:101349. https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101349.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"8650_CR111","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2337\/db08-0325","volume":"57","author":"F Pfister","year":"2008","unstructured":"Pfister F, Feng Y, Hagen F, Hoffmann S, Molema G, Hillebrands J-L, et al. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes. 2008;57(9):2495\u2013502. https:\/\/doi.org\/10.2337\/db08-0325.","journal-title":"Diabetes"},{"key":"8650_CR112","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jare.2024.01.016","volume":"67","author":"G Li","year":"2025","unstructured":"Li G, Gao J, Ding P, Gao Y. The role of endothelial cell\u2013pericyte interactions in vascularization and diseases. J Adv Res. 2025;67:269\u201388. https:\/\/doi.org\/10.1016\/j.jare.2024.01.016.","journal-title":"J Adv Res"},{"key":"8650_CR113","doi-asserted-by":"crossref","unstructured":"Grosche A, Grosche J, Verkhratsky A. Physiology and pathophysiology of the retinal neuroglia. Handb Clin Neurol. 2025;210.","DOI":"10.1016\/B978-0-443-19102-2.00017-X"},{"key":"8650_CR114","doi-asserted-by":"publisher","unstructured":"Balzamino BO, Cacciamani A, Dinice L, Cecere M, Pesci FR, Ripandelli G, et al. Retinal inflammation and reactive m\u00fcller cells: neurotrophins\u2019 release and neuroprotective strategies. Biology. 2024;13(12):1030. https:\/\/doi.org\/10.3390\/biology13121030.","DOI":"10.3390\/biology13121030"},{"key":"8650_CR115","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fncel.2024.1513686","volume":"18","author":"AE Medina-Arellano","year":"2024","unstructured":"Medina-Arellano AE, Albert-Garay JS, Medina-S\u00e1nchez T, Fonseca KH, Ruiz-Cruz M, Ochoa-de la Paz L. M\u00fcller cells and retinal angiogenesis: critical regulators in health and disease. Front Cell Neurosci. 2024;18:18. https:\/\/doi.org\/10.3389\/fncel.2024.1513686.","journal-title":"Front Cell Neurosci"},{"key":"8650_CR116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","volume":"162","author":"FS Sorrentino","year":"2016","unstructured":"Sorrentino FS, Allkabes M, Salsini G, Bonifazzi C, Perri P. The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci. 2016;162:54\u201359. https:\/\/doi.org\/10.1016\/j.lfs.2016.08.001.","journal-title":"Life Sci"},{"issue":"21","key":"8650_CR117","doi-asserted-by":"publisher","first-page":"12390","DOI":"10.1111\/jcmm.15739","volume":"24","author":"W Zhang","year":"2020","unstructured":"Zhang W, Kong Y. YAP is essential for TGF-\u03b2-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of m\u00fcller cells. J Cellular Mol Medi. 2020;24(21):12390\u2013400. https:\/\/doi.org\/10.1111\/jcmm.15739.","journal-title":"J Cellular Mol Medi"},{"key":"8650_CR118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2022.862325","volume":"16","author":"C Rosato","year":"2022","unstructured":"Rosato C, Bettegazzi B, Intagliata P, Balbontin Arenas M, Zacchetti D, Lanati A, et al. Redox and calcium alterations of a M\u00fcller cell line exposed to diabetic retinopathy-like environment. Front Cell Neurosci. 2022;16:16. https:\/\/doi.org\/10.3389\/fncel.2022.862325.","journal-title":"Front Cell Neurosci"},{"key":"8650_CR119","doi-asserted-by":"publisher","unstructured":"Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 2006. 2006;20, 20(12):1366\u201369. https:\/\/doi.org\/10.1038\/sj.eye.6702138.","DOI":"10.1038\/sj.eye.6702138"},{"issue":"3","key":"8650_CR120","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1167\/iovs.10-5768","volume":"52","author":"H Huang","year":"2011","unstructured":"Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, et al. TNF\u03b1 is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest. Ophthalmol Vis Sci. 2011;52(3):1336. https:\/\/doi.org\/10.1167\/iovs.10-5768.","journal-title":"Invest. Ophthalmol Vis Sci"},{"issue":"1","key":"8650_CR121","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1742-2094-9-178","volume":"9","author":"WS Qu","year":"2012","unstructured":"Qu WS, Tian DS, Guo ZB, Fang J, Zhang Q, Yu ZY, et al. Inhibition of EGFR\/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury. J Neuroinflammation. 2012;9(1):178. https:\/\/doi.org\/10.1186\/1742-2094-9-178.","journal-title":"J Neuroinflammation"},{"key":"8650_CR122","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2022.838007","volume":"16","author":"AD Rivera","year":"2022","unstructured":"Rivera AD, Azim K, Macchi V, Porzionato A, Butt AM, De Caro R. Epidermal growth factor pathway in the age-related decline of oligodendrocyte regeneration. Front Cell Neurosci. 2022;16:16. https:\/\/doi.org\/10.3389\/fncel.2022.838007.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"8650_CR123","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/cancers15030670","volume":"15","author":"A Dhawan","year":"2023","unstructured":"Dhawan A, Manem VSK, Yeaney G, Lathia JD, Ahluwalia MS, et al. EGFR pathway expression persists in recurrent glioblastoma Independent of amplification status. Cancers. 2023;15(3):670. https:\/\/doi.org\/10.3390\/cancers15030670.","journal-title":"Cancers"},{"issue":"4","key":"8650_CR124","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000101926","volume":"221","author":"F Yan","year":"2007","unstructured":"Yan F, Hui Y-N, Li Y-J, Guo C-M, Meng H. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Ophthalmologica. 2007;221(4):244\u201350. https:\/\/doi.org\/10.1159\/000101926.","journal-title":"Ophthalmologica"},{"issue":"2","key":"8650_CR125","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2741\/S398","volume":"S5","author":"L Zhang","year":"2013","unstructured":"Zhang L, et al. Migration of retinal pigment epithelial cells is EGFR PI3K AKT dependent. Front Biosci. 2013;S5(2):661\u201371. https:\/\/doi.org\/10.2741\/S398.","journal-title":"Front Biosci"},{"issue":"1","key":"8650_CR126","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbrc.2012.07.044","volume":"425","author":"C-H Wang","year":"2012","unstructured":"Wang C-H, Cao G-F, Jiang Q, Yao J. TNF-\u03b1 promotes human retinal pigment epithelial (RPE) cell migration by inducing matrix metallopeptidase 9 (MMP-9) expression through activation of Akt\/mTORC1 signaling. Biochem Bioph Res Co. 2012;425(1):33\u201338. https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.044.","journal-title":"Biochem Bioph Res Co"},{"issue":"23","key":"8650_CR127","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1161\/01.CIR.0000148780.36121.47","volume":"110","author":"PA Lucchesi","year":"2004","unstructured":"Lucchesi PA, Sabri A, Belmadani S, Matrougui K. Involvement of metalloproteinases 2\/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation. 2004;110(23):3587\u201393. https:\/\/doi.org\/10.1161\/01.CIR.0000148780.36121.47.","journal-title":"Circulation"},{"key":"8650_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/658548","volume":"2013","author":"G Mohammad","year":"2013","unstructured":"Mohammad G, Siddiquei MM, Nawaz MI, El-Asrar AMA. The ERK1\/2 inhibitor U0126 attenuates diabetes-induced Upregulation of MMP-9 and biomarkers of inflammation in the retina. J Diabetes Res. 2013;2013:1\u20139. https:\/\/doi.org\/10.1155\/2013\/658548.","journal-title":"J Diabetes Res"},{"key":"8650_CR129","doi-asserted-by":"publisher","unstructured":"Cho C-H, Roh K-H, Lim N-Y, Park SJ, Park S, Kim HW. Role of the JAK\/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model. Graefes Arch Clin Exp Ophthalmol. 2022;260, 260(11):3553\u201363. https:\/\/doi.org\/10.1007\/s00417-022-05694-7.","DOI":"10.1007\/s00417-022-05694-7"},{"key":"8650_CR130","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2016.10.009","volume":"384","author":"FYF Wang","year":"2017","unstructured":"Wang FYF, Kang C-S, Wang-Gou S-Y, Huang H, Feng C-Y, Li X-J. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. Cancer Lett. 2017;384:9\u201318. https:\/\/doi.org\/10.1016\/j.canlet.2016.10.009.","journal-title":"Cancer Lett"},{"issue":"1","key":"8650_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2025.12893","volume":"30","author":"HS Li","year":"2025","unstructured":"Li HS, Huang XG. Advances in the molecular signaling mechanisms of VEGF\/VEGFR2 in fundus neovascularization disease (review). Exp Ther Med. 2025;30(1):1\u201313. https:\/\/doi.org\/10.3892\/etm.2025.12893.","journal-title":"Exp Ther Med"},{"issue":"12","key":"8650_CR132","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00125-010-1900-z","volume":"53","author":"H Zong","year":"2010","unstructured":"Zong H, Ward M, Madden A, Yong PH, Limb GA, Curtis TM, et al. Hyperglycaemia-induced pro-inflammatory responses by retinal m\u00fcller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia. 2010;53(12):2656\u201366. https:\/\/doi.org\/10.1007\/s00125-010-1900-z.","journal-title":"Diabetologia"},{"issue":"9","key":"8650_CR133","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.2337\/diabetes.53.9.2404","volume":"53","author":"Z Dagher","year":"2004","unstructured":"Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 2004;53(9):2404\u201311. https:\/\/doi.org\/10.2337\/diabetes.53.9.2404.","journal-title":"Diabetes"},{"key":"8650_CR134","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molmet.2023.101736","volume":"73","author":"Y Wang","year":"2023","unstructured":"Wang Y, Eshwaran R, Beck SC, Hammes H-P, Wieland T, Feng Y. Contribution of the hexosamine biosynthetic pathway in the hyperglycemia-dependent and -independent breakdown of the retinal neurovascular unit. Mol Metab. 2023;73:73. https:\/\/doi.org\/10.1016\/j.molmet.2023.101736.","journal-title":"Mol Metab"},{"issue":"6","key":"8650_CR135","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/cells9061452","volume":"9","author":"MG Rossino","year":"2020","unstructured":"Rossino MG, Lulli M, Amato R, Cammalleri M, Monte MD, Casini G. Oxidative stress induces a VEGF autocrine loop in the retina: relevance for diabetic retinopathy. Cells. 2020;9(6):1452. https:\/\/doi.org\/10.3390\/cells9061452.","journal-title":"Cells"},{"issue":"10","key":"8650_CR136","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1167\/iovs.09-4899","volume":"51","author":"X Ye","year":"2010","unstructured":"Ye X, Xu G, Chang Q, Fan J, Sun Z, Qin Y, et al. ERK1\/2 signaling pathways involved in VEGF release in diabetic rat retina. Invest. Ophthalmol Vis Sci. 2010;51(10):5226. https:\/\/doi.org\/10.1167\/iovs.09-4899.","journal-title":"Invest. Ophthalmol Vis Sci"},{"issue":"3","key":"8650_CR137","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85(3):845\u201381. https:\/\/doi.org\/10.1152\/physrev.00021.2004.","journal-title":"Physiol Rev"},{"issue":"15","key":"8650_CR138","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.7150\/thno.71038","volume":"12","author":"S Z","year":"2022","unstructured":"Z S, Z T, C Y, Chu-Tan J, J K, L SR, et al. Inhibiting the activation of MAPK (ERK1\/2) in stressed m\u00fcller cells prevents photoreceptor degeneration. Theranostics. 2022;12(15):6705\u201322. https:\/\/doi.org\/10.7150\/thno.71038.","journal-title":"Theranostics"},{"issue":"11","key":"8650_CR139","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/biom13111630","volume":"13","author":"R Al-Dwairi","year":"2023","unstructured":"Al-Dwairi R, El-Elimat T, Aleshawi A, Sharie AHA, Mousa BMA, Beiruti SA, et al. Vitreous levels of vascular endothelial growth factor and platelet-derived growth factor in patients with proliferative diabetic retinopathy: a clinical correlation. Biomolecules. 2023;13(11):1630. https:\/\/doi.org\/10.3390\/biom13111630.","journal-title":"Biomolecules"},{"issue":"6","key":"8650_CR140","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/dvdy.24628","volume":"247","author":"M Lee","year":"2018","unstructured":"Lee M, Goraya N, Kim S, Cho S-H. Hippo-Yap signaling in ocular development and disease. Dev Dyn: Off Publ Am Assoc Anatomists. 2018;247(6):794\u2013806. https:\/\/doi.org\/10.1002\/dvdy.24628.","journal-title":"Dev Dyn: Off Publ The Am Assoc Anatomists"},{"issue":"9","key":"8650_CR141","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/156652410793937813","volume":"10","author":"J R. Sparrrow","year":"2010","unstructured":"R. Sparrrow J, Hicks D, Hamel C. The retinal pigment epithelium in health and disease. CMM. 2010;10(9):802\u201323. https:\/\/doi.org\/10.2174\/156652410793937813.","journal-title":"CMM"},{"issue":"2","key":"8650_CR142","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4239\/wjd.v1.i2.57","volume":"1","author":"M Villarroel","year":"2010","unstructured":"Villarroel M. Neurodegeneration: an early event of diabetic retinopathy. WJD. 2010;1(2):57. https:\/\/doi.org\/10.4239\/wjd.v1.i2.57.","journal-title":"WJD"},{"key":"8650_CR143","doi-asserted-by":"publisher","unstructured":"Zafar S, Sachdeva M, Frankfort BJ, Channa R. Retinal neurodegeneration as an Early manifestation of diabetic eye disease and potential neuroprotective therapies. Curr Diab Rep. 2019;19(4). https:\/\/doi.org\/10.1007\/s11892-019-1134-5.","DOI":"10.1007\/s11892-019-1134-5"},{"key":"8650_CR144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.73218","volume":"10","author":"Y Huang","year":"2021","unstructured":"Huang Y, Ognjenovic J, Karandur D, Miller K, Merk A, Subramaniam S, et al. A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor. Elife. 2021;10:10. https:\/\/doi.org\/10.7554\/eLife.73218.","journal-title":"Elife"},{"issue":"3","key":"8650_CR145","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2017.09.017","volume":"171","author":"DM Freed","year":"2017","unstructured":"Freed DM, Bessman NJ, Kiyatkin A, Salazar-Cavazos E, Byrne PO, Moore JO, et al. EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics. Cell. 2017;171(3):683\u201395.e18. https:\/\/doi.org\/10.1016\/j.cell.2017.09.017.","journal-title":"Cell"},{"key":"8650_CR146","doi-asserted-by":"publisher","unstructured":"Klaassen I, de Vries EW, Vogels IMC, van Kampen AHC, Bosscha MI, Steel DHW, et al. Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes. PLoS One. 2017;12(11):e0187304. https:\/\/doi.org\/10.1371\/journal.pone.0187304.","DOI":"10.1371\/journal.pone.0187304"},{"issue":"3","key":"8650_CR147","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/dom.13538","volume":"21","author":"SC Bain","year":"2019","unstructured":"Bain SC, Klufas MA, Ho A, Matthews DR. Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review. Diabetes Obes Metab. 2019;21(3):454\u201366. https:\/\/doi.org\/10.1111\/dom.13538.","journal-title":"Diabetes Obes Metab"},{"key":"8650_CR148","doi-asserted-by":"publisher","unstructured":"Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes. 1997;46(Supplement_2):S26\u201330. https:\/\/doi.org\/10.2337\/diab.46.2.S26.","DOI":"10.2337\/diab.46.2.S26"},{"key":"8650_CR149","doi-asserted-by":"publisher","unstructured":"You M XX, Xia X, Li H, Wu J, Rong R, Zeng Z, et al. Normal vitreous promotes angiogenesi via the epidermal growth factor receptor. Faseb J. 2020;34(11):14799\u2013809. https:\/\/doi.org\/10.1096\/fj.201902862RRR.","DOI":"10.1096\/fj.201902862RRR"},{"issue":"4","key":"8650_CR150","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1089\/met.2019.0120","volume":"18","author":"S Kim","year":"2020","unstructured":"Kim S, Subramanian V, Abdel-Latif A, Lee S. Role of heparin-binding epidermal growth factor-like growth factor in oxidative stress-associated metabolic diseases. Metab Syndr Relat Disord. 2020;18(4):186\u201396. https:\/\/doi.org\/10.1089\/met.2019.0120.","journal-title":"Metab Syndr Relat Disord"},{"key":"8650_CR151","doi-asserted-by":"publisher","unstructured":"Guaiquil VH, Swendeman S, Zhou W, Guaiquil P, Weskamp G, Bartsch JW, et al. ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice. J Mol Med. 2010;88, 88(5):497\u2013505. https:\/\/doi.org\/10.1007\/s00109-010-0591-8.","DOI":"10.1007\/s00109-010-0591-8"},{"key":"8650_CR152","doi-asserted-by":"publisher","unstructured":"Ding Y, Zhang Y, Zhang L. The role of the neuregulin 1-ErbB4 signaling pathway in neurological disorders. J Physiol Pharmacol. 2024;75(6). https:\/\/doi.org\/10.26402\/jpp.2024.6.01.","DOI":"10.26402\/jpp.2024.6.01"},{"key":"8650_CR153","first-page":"253","volume-title":"Neuroglia","author":"T Mbd-Ed-Sp","year":"2023","unstructured":"Mbd-Ed-Sp T, Donatella. The signaling of Neuregulin-epidermal growth factor receptors and its impact on the nervous System. In: Palmieri Mbd-Ed-Sp, Alessandro, editors. Neuroglia. Basel, Switzerland: MDPI; 2023. p. 253\u201374."},{"issue":"7","key":"8650_CR154","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/glia.23150","volume":"65","author":"A Alizadeh","year":"2017","unstructured":"Alizadeh A, Dyck SM, Kataria H, Shahriary GM, Nguyen DH, Santhosh KT, et al. Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia. 2017;65(7):1152\u201375. https:\/\/doi.org\/10.1002\/glia.23150.","journal-title":"Glia"},{"issue":"6","key":"8650_CR155","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.peptides.2011.04.005","volume":"32","author":"Z Liu","year":"2011","unstructured":"Liu Z, Gao W, Wang Y, Zhang W, Liu H, Li Z. Neuregulin-1\u03b2 regulates outgrowth of neurites and migration of neurofilament 200 neurons from dorsal root ganglial explants in vitro. Peptides. 2011;32(6):1244\u201348. https:\/\/doi.org\/10.1016\/j.peptides.2011.04.005.","journal-title":"Peptides"},{"key":"8650_CR156","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fncel.2017.00431","volume":"11","author":"G M\u00f2dol-Caballero","year":"2018","unstructured":"M\u00f2dol-Caballero G, Santos D, Navarro X, Herrando-Grabulosa M. Neuregulin 1 reduces motoneuron cell death and promotes neurite growth in an in vitro Model of motoneuron degeneration. Front Cell Neurosci. 2018;11:431. https:\/\/doi.org\/10.3389\/fncel.2017.00431.","journal-title":"Front Cell Neurosci"},{"key":"8650_CR157","doi-asserted-by":"publisher","unstructured":"Kocak MZ, Aktas G, Atak BM, Duman TT, Yis OM, Erkus E, et al. Is neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Investigation. 2020;50(3). https:\/\/doi.org\/10.1111\/eci.13206.","DOI":"10.1111\/eci.13206"},{"issue":"1","key":"8650_CR158","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-020-00550-2","volume":"12","author":"P Yan","year":"2020","unstructured":"Yan P, Zhang Z, Miao Y, Xu Y, Zhu J, Wan Q. Changes of circulating neuregulin 4 and its relationship with 25-hydroxy vitamin D and other diabetic vascular complications in patients with diabetic peripheral neuropathy. Diabetol Metab Syndr. 2020;12(1):42. https:\/\/doi.org\/10.1186\/s13098-020-00550-2.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"8650_CR159","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.ajpath.2018.07.016","volume":"188","author":"DT Dao","year":"2018","unstructured":"Dao DT, Anez-Bustillos L, Adam RM, Puder M, Bielenberg DR. Heparin-binding epidermal growth factor\u2013like growth factor as a critical mediator of tissue repair and regeneration. Am J Pathol. 2018;188(11):2446\u201356. https:\/\/doi.org\/10.1016\/j.ajpath.2018.07.016.","journal-title":"Am J Pathol"},{"issue":"7","key":"8650_CR160","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1634\/theoncologist.10-7-461","volume":"10","author":"MH Cohen","year":"2005","unstructured":"Cohen MH, Johnson JR, Chen Y-F, Sridhara R, Pazdur R. FDA drug approval summary: erlotinib (Tarceva\u00ae) tablets. Oncologist. 2005;10(7):461\u201366. https:\/\/doi.org\/10.1634\/theoncologist.10-7-461.","journal-title":"Oncologist"},{"issue":"6","key":"8650_CR161","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1158\/1078-0432.CCR-15-2266","volume":"22","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D, Blumenthal GM, Yuan W, He K, Keegan P, Pazdur R. FDA approval of gefitinib for the treatment of patients with metastatic EGFR mutation\u2013positive non\u2013small cell lung cancer. Clin Cancer Res. 2016;22(6):1307\u201312. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2266.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"8650_CR162","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/jamaoncol.2025.3136","volume":"11","author":"W Hwang","year":"2025","unstructured":"Hwang W, Ahn JS, Jung HA, Wirth LJ, Park JC. Emerging EGFR-Targeted therapy in head and neck cancer. JAMA Oncol. 2025;11(11):1373. https:\/\/doi.org\/10.1001\/jamaoncol.2025.3136.","journal-title":"JAMA Oncol"},{"issue":"6","key":"8650_CR163","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1021\/nn103146p","volume":"5","author":"R Robinson","year":"2011","unstructured":"Robinson R, Viviano SR, Criscione JM, Williams CA, Jun L, Tsai JC, et al. Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery. ACS Nano. 2011;5(6):4392\u2013400. https:\/\/doi.org\/10.1021\/nn103146p.","journal-title":"ACS Nano"},{"issue":"9","key":"8650_CR164","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/17425247.2025.2516668","volume":"22","author":"H Kadavil","year":"2025","unstructured":"Kadavil H, Adib SA, Marei A, Al-Qahtani NH, Zhu Y, Al-Kinani AA, et al. Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications. Expert Opin Drug Delivery. 2025;22(9):1275\u2013301. https:\/\/doi.org\/10.1080\/17425247.2025.2516668.","journal-title":"Expert Opin Drug Delivery"},{"issue":"8","key":"8650_CR165","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/14656566.2025.2496424","volume":"26","author":"LW Rowe Lw","year":"2025","unstructured":"Rowe Lw LW, Akotoye C, Harris TA, Ciulla TA. Beyond the injection: delivery systems reshaping retinal disease management. Expert Opin Pharmacother. 2025;26(8):939\u201352. https:\/\/doi.org\/10.1080\/14656566.2025.2496424.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"8650_CR166","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/1061186X.2024.2443144","volume":"33","author":"P Panda P","year":"2025","unstructured":"Panda P P, Mohanty SR, Gouda R, Mohapatra R. Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes. J Drug Targeting. 2025;33(5):587\u2013611. https:\/\/doi.org\/10.1080\/1061186X.2024.2443144.","journal-title":"J Drug Targeting"},{"issue":"2","key":"8650_CR167","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","volume":"16","author":"X Le","year":"2021","unstructured":"Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, et al. Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-Mutant NSCLC. J Thorac Oncol. 2021;16(2):205\u201315. https:\/\/doi.org\/10.1016\/j.jtho.2020.10.006.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"8650_CR168","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","volume":"35","author":"AM Joussen","year":"2021","unstructured":"Joussen AM, Ricci F, Paris LP, Korn C, Quezada-Ruiz C, Zarbin M, et al. Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye. 2021;35(5):1305\u201316. https:\/\/doi.org\/10.1038\/s41433-020-01377-x.","journal-title":"Eye"},{"issue":"10326","key":"8650_CR169","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","volume":"399","author":"CC Wykoff","year":"2022","unstructured":"Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, et al. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022;399(10326):741\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(22)00018-6.","journal-title":"Lancet"},{"issue":"1","key":"8650_CR170","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","volume":"33","author":"SV Reddy","year":"2018","unstructured":"Reddy SV, Husain D. Panretinal photocoagulation: a review of complications. Semin Ophthalmol. 2018;33(1):83\u201388. https:\/\/doi.org\/10.1080\/08820538.2017.1353820.","journal-title":"Semin Ophthalmol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08650-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:40:25Z","timestamp":1792453225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08650-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8650"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08650-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors consent to the publication of this work.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1321"}}